BioAtla, Inc.BCABNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P33
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-15.83%
2023-9.85%
2022-25.05%
2021262.59%
202040.35%
2019-39.88%
20180.00%